FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025469374> ?p ?o ?g. }

• W2025469374 endingPage "799" @default.
• W2025469374 startingPage "793" @default.
• W2025469374 abstract "Objectives: To study the efficacy and safety of 1 year of growth hormone (GH) therapy in children with steroid-dependent nephrotic syndrome. Study design: A prospective pilot, open study in which GH (mean dose 0.32 mg/kg per week) was administered for 1 year to 8 children with steroid-dependent nephrotic syndrome requiring prednisolone (mean dose 0.46 mg/kg per day) to maintain remission. Steroid dependence was defined as recurrence of proteinuria within 2 weeks of discontinuation of prednisolone, or when the dose was lowered below a critical level. At entry, all patients had been steroid dependent for at least 1 year. Anthropometric and bone mineral density measurements after treatment were compared with 1-year pretreatment data. Results: Pretreatment mean (±SD) chronologic age was 12.6 (±3.1) years, with a mean bone age of 9.1 (±2.0) years, with delayed puberty in five patients. The mean height velocity increased from 3.7 (±1.4) to 9.4 (±2.1) cm/yr after 1 year of treatment (p<0.05). The mean height standard deviation score increased from −1.4 (±1.6) to −0.3 (±1.1), (p<0.05). In the spine, the mean bone mineral density increased from 0.50 to 0.64 gm/cm2 (p<0.05), and in the femoral neck, from 0.55 to 0.64 gm/cm2 (p<0.05) after 1 year of treatment. Mean lean body mass increased from 58.1% to 62.6% (p<0.01). There were no significant changes in creatinine clearance, fasting glucose, fasting insulin, or glycosylated hemoglobin levels. The mean bone age increased to 11.4 (±2.4) years, and pubertal stage advanced in 2 patients. Conclusion: One year of GH therapy is effective in improving the height standard deviation score, height velocity, bone mineral density, and lean body mass of children with steroid-dependent nephrotic syndrome. There were no significant adverse effects. However, the bone age accelerated at a greater pace than the height age, and further studies are required to define the role of GH therapy in steroid-dependent nephrotic syndrome. Objectives: To study the efficacy and safety of 1 year of growth hormone (GH) therapy in children with steroid-dependent nephrotic syndrome. Study design: A prospective pilot, open study in which GH (mean dose 0.32 mg/kg per week) was administered for 1 year to 8 children with steroid-dependent nephrotic syndrome requiring prednisolone (mean dose 0.46 mg/kg per day) to maintain remission. Steroid dependence was defined as recurrence of proteinuria within 2 weeks of discontinuation of prednisolone, or when the dose was lowered below a critical level. At entry, all patients had been steroid dependent for at least 1 year. Anthropometric and bone mineral density measurements after treatment were compared with 1-year pretreatment data. Results: Pretreatment mean (±SD) chronologic age was 12.6 (±3.1) years, with a mean bone age of 9.1 (±2.0) years, with delayed puberty in five patients. The mean height velocity increased from 3.7 (±1.4) to 9.4 (±2.1) cm/yr after 1 year of treatment (p<0.05). The mean height standard deviation score increased from −1.4 (±1.6) to −0.3 (±1.1), (p<0.05). In the spine, the mean bone mineral density increased from 0.50 to 0.64 gm/cm2 (p<0.05), and in the femoral neck, from 0.55 to 0.64 gm/cm2 (p<0.05) after 1 year of treatment. Mean lean body mass increased from 58.1% to 62.6% (p<0.01). There were no significant changes in creatinine clearance, fasting glucose, fasting insulin, or glycosylated hemoglobin levels. The mean bone age increased to 11.4 (±2.4) years, and pubertal stage advanced in 2 patients. Conclusion: One year of GH therapy is effective in improving the height standard deviation score, height velocity, bone mineral density, and lean body mass of children with steroid-dependent nephrotic syndrome. There were no significant adverse effects. However, the bone age accelerated at a greater pace than the height age, and further studies are required to define the role of GH therapy in steroid-dependent nephrotic syndrome." @default.
• W2025469374 created "2016-06-24" @default.
• W2025469374 creator A5037355737 @default.
• W2025469374 creator A5040570732 @default.
• W2025469374 creator A5050920027 @default.
• W2025469374 creator A5065652574 @default.
• W2025469374 creator A5075695076 @default.
• W2025469374 creator A5082587283 @default.
• W2025469374 date "1997-05-01" @default.
• W2025469374 modified "2023-10-16" @default.
• W2025469374 title "Efficacy and safety of one year of growth hormone therapy in steroid-dependent nephrotic syndrome" @default.
• W2025469374 cites W131018175 @default.
• W2025469374 cites W1970122356 @default.
• W2025469374 cites W1972297313 @default.
• W2025469374 cites W1984035921 @default.
• W2025469374 cites W1986607163 @default.
• W2025469374 cites W2010645042 @default.
• W2025469374 cites W2028991101 @default.
• W2025469374 cites W2058338892 @default.
• W2025469374 cites W2065879561 @default.
• W2025469374 cites W2070580000 @default.
• W2025469374 cites W2085732256 @default.
• W2025469374 cites W2088467187 @default.
• W2025469374 cites W2090931563 @default.
• W2025469374 cites W2095733494 @default.
• W2025469374 cites W2137272395 @default.
• W2025469374 cites W2139917239 @default.
• W2025469374 cites W2316127871 @default.
• W2025469374 cites W2331609610 @default.
• W2025469374 doi "https://doi.org/10.1016/s0022-3476(97)80023-6" @default.
• W2025469374 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9152290" @default.
• W2025469374 hasPublicationYear "1997" @default.
• W2025469374 type Work @default.
• W2025469374 sameAs 2025469374 @default.
• W2025469374 citedByCount "14" @default.
• W2025469374 countsByYear W20254693742013 @default.
• W2025469374 countsByYear W20254693742023 @default.
• W2025469374 crossrefType "journal-article" @default.
• W2025469374 hasAuthorship W2025469374A5037355737 @default.
• W2025469374 hasAuthorship W2025469374A5040570732 @default.
• W2025469374 hasAuthorship W2025469374A5050920027 @default.
• W2025469374 hasAuthorship W2025469374A5065652574 @default.
• W2025469374 hasAuthorship W2025469374A5075695076 @default.
• W2025469374 hasAuthorship W2025469374A5082587283 @default.
• W2025469374 hasConcept C126322002 @default.
• W2025469374 hasConcept C126894567 @default.
• W2025469374 hasConcept C134018914 @default.
• W2025469374 hasConcept C2776541429 @default.
• W2025469374 hasConcept C2776715498 @default.
• W2025469374 hasConcept C2776886416 @default.
• W2025469374 hasConcept C2778715236 @default.
• W2025469374 hasConcept C2778930706 @default.
• W2025469374 hasConcept C2780306776 @default.
• W2025469374 hasConcept C71924100 @default.
• W2025469374 hasConcept C89551170 @default.
• W2025469374 hasConcept C90924648 @default.
• W2025469374 hasConceptScore W2025469374C126322002 @default.
• W2025469374 hasConceptScore W2025469374C126894567 @default.
• W2025469374 hasConceptScore W2025469374C134018914 @default.
• W2025469374 hasConceptScore W2025469374C2776541429 @default.
• W2025469374 hasConceptScore W2025469374C2776715498 @default.
• W2025469374 hasConceptScore W2025469374C2776886416 @default.
• W2025469374 hasConceptScore W2025469374C2778715236 @default.
• W2025469374 hasConceptScore W2025469374C2778930706 @default.
• W2025469374 hasConceptScore W2025469374C2780306776 @default.
• W2025469374 hasConceptScore W2025469374C71924100 @default.
• W2025469374 hasConceptScore W2025469374C89551170 @default.
• W2025469374 hasConceptScore W2025469374C90924648 @default.
• W2025469374 hasFunder F4320317196 @default.
• W2025469374 hasFunder F4320320698 @default.
• W2025469374 hasFunder F4320322436 @default.
• W2025469374 hasIssue "5" @default.
• W2025469374 hasLocation W20254693741 @default.
• W2025469374 hasLocation W20254693742 @default.
• W2025469374 hasOpenAccess W2025469374 @default.
• W2025469374 hasPrimaryLocation W20254693741 @default.
• W2025469374 hasRelatedWork W1683611218 @default.
• W2025469374 hasRelatedWork W1985732893 @default.
• W2025469374 hasRelatedWork W2004593025 @default.
• W2025469374 hasRelatedWork W2044054235 @default.
• W2025469374 hasRelatedWork W2077370951 @default.
• W2025469374 hasRelatedWork W2088812049 @default.
• W2025469374 hasRelatedWork W2117992582 @default.
• W2025469374 hasRelatedWork W2134223583 @default.
• W2025469374 hasRelatedWork W4243440205 @default.
• W2025469374 hasRelatedWork W2099549640 @default.
• W2025469374 hasVolume "130" @default.
• W2025469374 isParatext "false" @default.
• W2025469374 isRetracted "false" @default.
• W2025469374 magId "2025469374" @default.
• W2025469374 workType "article" @default.